Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Four Communications

Article: What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Read his latest article for PME Magazine.https://bit.ly/31ef6rh

Research Partnership

- PMLiVE

Why pharma must trust the science of behaviour

With behaviour being the best weapon we currently have to combat coronavirus, Chris Ross explores why the application of behavioural science will be key to better health far beyond COVID-19

The Uptake of Digital Technologies in Healthcare

In this Fireside Chat, Natalie Yeadon sat down with Anand Iyer, Chief Strategy Officer at Welldoc and discussed a myriad of different topics, including AI and MR in healthcare and...

Impetus Digital

Onyx Health Expands with New Management Appointment

Onyx Health have continued to grow throughout the COVID-19 downturn and have expanded the agency further by appointing Alix Stonehouse as their new Account Manager

Onyx Health

- PMLiVE

Media Means Business

Creating meaningful media experiences in pharma

Havas Lynx

Top 5 tips for a multi-indication product launch

Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.

Blue Latitude Health

- PMLiVE

Bedrock Group strengthens its senior team

Bedrock Healthcare Communications have strengthened its senior management team

Bedrock Healthcare Communications

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

Research Partnership

News: Living with Ulcerative Colitis and Crohn’s Disease

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports...

Research Partnership

Onyx Health Tackles Diabetes with New Client

Onyx Health have continued to grow as an agency during the COVID-19 downturn, expanding their business into the South East of England by winning a new Surrey based client.

Onyx Health

Impetus Digital Fireside Chat with Tom Hsu, VP, Specialty Medicine at Bayer Canada

Tom Hsu, VP of Specialty Medicine at Bayer Canada,  talks about how he got to where he is today and his experience working for Bayer in China, and how that compares to...

Impetus Digital

Onyx Health Launch VR Learning Platform in Response to COVID-19

Onyx Health are launching a new Interactive Learning Environment (ILE) to revolutionise healthcare communication

Onyx Health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links